BaschantURaunerMBalaianEWeidnerHRoettoAPlatzbeckerUet al
Hellstrom PM, Hein J, Bytzer P, Bjornsson E, Kristensen J, Schambye H (2009) Clinical trial: the glucagon-like peptide-1 analogue ROSE-010 for management of acute pain in patients with irritable bowel syndrome: a randomized, placebo-controlled, double-blind study
And the numbers continue to rise
When choosing an immune system support formula, safety and efficacy are the only two factors that truly matter
its a mimic of a hormone your body already produces
However, how your body responds to this dose depends on multiple factors: genetic variants in GIPR pathways, baseline metabolic markers, body composition, and individual pharmacokinetics